KAI-1455 is a selective epsilon protein kinase C (εPKC) activator designed to reduce ischemic organ injury during procedures where blood supply may be compromised, such as coronary artery bypass grafting (CABG), congenital cardiac defect repair, and hip replacement and may protect against renal injury associated with contrast media.
CAT# | 10-101-145 |
Synonyms/Alias | KAI 1455;KAI1455 |
M.F/Formula | C109H180N44O30S2 |
M.W/Mr. | 2652 |
Sequence | H-Cys(1)-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-OH. H-Cys(1)-His-Asp-Ala-Pro-Ile-Gly-Tyr-Asp-OH |
Labeling Target | Epsilon protein kinase C (εPKC) |
Activity | Activator |
Functions | Signal transducer activity |
Target | εPKC |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Corticotropin (ACTH or adrenocorticotropic hormone) is a linear coupling of 39 amino acid residues and an import ...
Figure 1. Chemical structure of pentagastrinPentagastrin, known as peptavlon, is a synthetic pentapeptide that p ...
Caprooyl tetrapeptide-3, an anti-wrinkle peptide, a reaction product of caproic acid and tetrapeptide-3, compris ...
Background Signal peptides stimulate matrix protein production in general and collagen synthesis in specific. They may be acc ...
Sincalide is a brain and intestinal skin with a variety of physiological effects. It is widely distributed in th ...